Human NK cells express cell surface class I MHC receptors (killer cell immunoglobulin-like receptor, KIR) in a probabilistic manner. Previous studies have shown that a distal promoter acts in conjunction with a proximal bidirectional promoter to control the selective activation of KIR genes. We report here the presence of an intron 2 promoter in several KIR genes that produce a spliced antisense transcript. This long noncoding RNA (lncRNA) transcript contains antisense sequence complementary to KIR-coding exons 1 and 2 as well as the proximal promoter region of the KIR genes. The antisense promoter contains myeloid zinc finger 1 (MZF-1)binding sites, a transcription factor found in hematopoietic progenitors and myeloid precursors. The KIR antisense lncRNA was detected only in progenitor cells or pluripotent cell lines, suggesting a function that is specific for stem cells. Overexpression of MZF-1 in developing NK cells led to decreased KIR expression, consistent with a role for the KIR antisense lncRNA in silencing KIR gene expression early in development.
INTRODUCTION
Natural killer (NK) cells are an important component of the innate immune system wherein resides the ability to eliminate virally infected and tumor cells without prior sensitization. 1 The cytolytic activity of NK cells is modulated by the presence or absence of class I MHC molecules on target cells. 2 The interplay between activating and inhibitory receptors present on NK cells and their respective ligands on potential targets determines if cells are killed or spared.
NK cells use cell-surface receptors for class I MHC to evaluate the status of target cells. The major type of class I receptor expressed by human NK cells is the killer cell immunoglobulin-like receptor (KIR) family. 3, 4 In contrast, the functionally analogous murine inhibitory receptors are members of the C-type lectin family (Ly49 receptor family). 5 The expression of KIR and Ly49 on NK cells is variegated, with distinct subsets of NK cells displaying different combinations of receptors generated by a stochastic process. 6, 7 The ability of adjacent KIR genes to be differentially expressed is controlled by DNA methylation of the proximal promoter region. 8, 9 The KIR loci are fully methylated in NK progenitors; however, once activated, the proximal KIR promoter remains in a demethylated state and the gene is continuously transcribed. KIR expression is associated with fully differentiated, functional NK cells, and KIR have been shown to play a major role in the growth, differentiation and function of NK cells. 10 Previous studies from our group have demonstrated that the variegated expression of both Ly49 and KIR genes is determined by a stochastic switch operating in the promoter region. [11] [12] [13] In the murine Ly49 genes, a probabilistic bidirectional promoter active in immature NK cells is present upstream of the proximal promoter responsible for Ly49 expression in mature NK cells. The choice of forward transcription from this upstream element (Pro1) leads to the activation of the proximal promoter. The expression of a Ly49 gene from the proximal promoter is dependent on distal transcription, as Pro1 deletion abrogates Ly49 transcription. 14 In contrast, the human KIR genes possess a proximal promoter with bidirectional transcriptional activity, whereas an upstream distal promoter is unidirectional. Similar to the Ly49 genes, the distal KIR promoter is active in committed NK progenitors, and distal transcription is associated with activation of the proximal promoter. 15, 16 The location of the bidirectional promoter downstream of the distal promoter leads to the generation of opposing transcripts if antisense transcription is initiated from the proximal promoter. 17 The presence of dsRNA leads to the production of a 28-base antisense RNA with the properties of a Piwi RNA. 18 The Piwi class of small RNAs has been associated with gene silencing in germ cells, and recent studies have demonstrated the presence of these RNAs in somatic cell types as well. 19 Forced expression of proximal promoter antisense transcripts in developing NK cells leads to reduced KIR expression, and the 28-base element is essential for this suppression. 18 The data presented in the current study reveal the presence of an additional antisense transcript in the 2DL1/S1 and 3DL1/S1 genes. The transcript is generated from a promoter in the second intron, and represents a spliced, polyadenylated RNA that appears to be noncoding. Overlap of this transcript with the proximal antisense transcript leads to the production of the previously characterized 28-base piRNA from this long noncoding RNA (lncRNA), and enforced expression of the distal antisense also leads to suppressed KIR expression. Our characterization of the promoter and transcript indicates activity only in pluripotent cells, suggesting a functional role for the antisense transcript in the initial silencing of the KIR loci.
RESULTS

Detection of a distal antisense KIR transcript
Our previous reports demonstrated that human KIR genes all contain a proximal promoter that is bidirectional in nature. 12 Experiments designed to determine the 5 0 start site for the proximal KIR2DL1 antisense transcript were conducted with RNA from the HEK293 cell line as a non-NK control. However, when HEK293 RNA was used, a transcript was identified that originated within intron 2 of the KIR2DL1/S1 gene. To determine if the antisense was also found in the 3D class of KIR, primers specific for the KIR3DL1 gene were also used to isolate antisense transcripts from the KIR3DL1/S1 genes. This novel antisense transcript is referred to as the KIR distal antisense in order to distinguish it from the proximal promoter-derived antisense transcripts that we have previously described. 12 The transcriptional start site for the KIR2DL1 distal antisense is located within the second intron, 181 nucleotides downstream of the second KIR-coding exon ( Figure 1a ). The KIR3DL1 distal antisense transcript starts 81 nucleotides downstream of exon 2. Two distinct alternatively spliced distal antisense transcripts of 710 and 781 nucleotides, each consisting of three exons, were cloned for the KIR2DL1 gene (GenBank accession numbers GQ422372 and GQ422373), whereas only one 825-nucleotide transcript consisting of two exons was cloned for the KIR3DL1 gene (GenBank accession number GQ422374). The distal antisense transcript has a complete overlap with exons 1 and 2 of the KIR-coding transcript as well as the proximal antisense transcript ( Figure 1a ). Interestingly, the splice acceptor for the final antisense exon is only 7 bp downstream of the exon 1 splice donor of the sense KIR transcript, suggesting that the splice site definition signals or splicing enhancers are shared ( Figure 1b ). In addition, although the distal antisense transcripts have their respective start sites in intron 2, the polyadenylation signals are shared with the proximal antisense transcript. 12 KIR distal antisense transcripts are not present in differentiated cells The presence of spliced distal antisense transcript was determined by RT-PCR with forward primers from regions not contained in sense or proximal antisense KIR2DL1 or KIR3DL1 transcripts (see Materials and methods). The non-spliced, proximal antisense transcripts were detected using the 3 0 -rapid amplification of cDNA ends (3 0 -RACE) technique previously described. 12 This technique produced positive signals in the cell types containing distal antisense due to the complete overlap of the distal antisense with the proximal transcript. However, the antisense transcripts were confirmed to originate only from the distal promoter by 5 0 -RACE analysis. Table 1 shows the results of a survey of various human tissues and cell lines for the presence of KIR2DL1 and KIR3DL1 distal antisense (first column, both genes detected when positive) or antisense derived from the proximal promoter (second column, KIR gene of origin is indicated). Spliced KIR2DL1 and KIR3DL1 distal antisense transcripts were detected in RNA from several cell lines, including U937 (promonocytic leukemia), HEK293T (human embryonic kidney), Ntera2 (human embryonic carcinoma) and H9 (human embryonic stem cell). The only freshly isolated tissue found to contain distal antisense was cord blood, possibly due to the presence of a small population of pluripotent cells. RNA from peripheral blood NK cells, monocytes, CD34-positive cord blood or H9 ES cells differentiated into CD34 þ cells did not express the distal antisense. Furthermore, cell lines representing differentiated lymphoid cell types such as YT (NK), Daudi (B) and Jurkat (T) did not contain distal antisense RNA. Interestingly, the NK3.3 cell line contained KIR2DL2 proximal antisense, whereas the Daudi and Jurkat lines contained an unusual proximal antisense transcript of the KIR3DP1 pseudogene that originated in intron 1 as determined by 5 0 -RACE analysis. The cell lines where the distal antisense transcript was detected represent early developmental stages. The distal antisense transcript was not detected in mature NK-like, B and T cell lines indicating that it may be present only in early progenitor cell types.
Characterization of the KIR intron 2 promoter elements
In order to gain insight into the observed preferential expression of KIR distal antisense in stem cell populations, the putative intron 2 promoter regions of the KIR2DL1 and KIR3DL1 genes were investigated. A large series of PCR-generated DNA segments in the vicinity of the observed transcriptional start sites was analyzed by cloning into the pGL3-basic luciferase reporter vector. Constructs shown. Black rectangles represent promoter elements, and numbered rectangles represent exons. Lines represent KIR transcripts with their orientation indicated by arrows. The exon structure of the KIR2DL1/S1 and KIR3DL1/S1 distal antisense transcripts is indicated below. The additional exon sequence found in the KIR2DL1 alternative transcript (GenBank: GQ422373) is indicated by the dotted rectangle. (b) The nucleotide sequence of the region containing the KIR2DL1 distal antisense intron 2/exon 3 splice junction and the exon 1/intron 1 splice junction of the KIR2DL1coding transcript is shown. The antisense strand is shown on top with the complementary coding sense strand shown on the bottom. Consensus splice acceptor (antisense) and splice donor (sense) sequences are underlined in bold. 
þ À a KIR2DL1 and KIR3DL1 transcripts detected with primers listed in Materials and Methods. b KIR proximal antisense transcripts detected as previously described 12 . The identity of the KIR gene detected is listed in parentheses.
Progenitor cells and KIR antisense lncRNA expression PW Wright et al were evaluated by transfection into the HEK293, Ntera2 and YT cell lines. None of the fragments tested showed any activity in the YT cell line, consistent with the lack of antisense transcripts in these cells (data not shown). Figure 2a shows the results of transfection of KIR2DL1 promoter constructs into HEK293. The highest promoter activity was detected in fragments that contained a central binding site for the myeloid zinc finger 1 (MZF-1) transcription factor together with putative C/EBP and MYC sites located downstream (constructs 7-9). Addition of a 5 0 sequence containing additional putative combined AML-1/MZF-1 or NF-kB/AML-1 elements resulted in decreased activity (constructs 1-5). MZF-1 is a transcription factor belonging to the Krü ppel family of zinc finger proteins, and it possesses two DNA-binding domains. 20, 21 The first domain binds to the core sequence 5 0 -AGTGGGGA-3 0 , and the second domain binds to the core sequence 5 0 -CGGGNGAGGGGGAA-3 0 . MZF-1 is expressed by totipotent hematopoietic cells as well as by myeloid progenitors, and therefore may contribute to the preferential activity of the distal antisense promoter in stem cells. Constructs lacking the central MZF-1 site (constructs 4 and 12) did not demonstrate significant promoter activity, indicating a key role for MZF-1. Core promoter activity was localized to a 135-bp region containing a putative binding site for the MZF-1 protein at the 5 0 end, a MZF-1 half-site in the middle, and potential C/EBP and MYC-binding sites at the 3 0 end (construct 9). Mutation of the MZF-1 site produced a 30% decrease in promoter activity (construct 10). Although deletion of the 3 0 region containing the C/EBP and MYC sites significantly decreased promoter activity, a core construct with mutations in the 3 0 C/EBP and MYC site did not decrease promoter activity (construct 11), indicating that MZF-1 is likely the major transcription factor driving promoter activity. The specificity of the promoter for pluripotent cell types was examined by transfection of construct 7 into the following additional cell lines: Ntera2, H9 ES, MCF7, PC3, YT and Hela (Figure 2b ). As expected, promoter activity was detected only in the cell lines that were shown to express KIR distal antisense transcripts by RT-PCR.
EMSA analysis of the core MZF-1 site in YT and HEK293 cell extracts In order to investigate whether the putative MZF-1-binding site could account for the tissue specificity of the distal antisense core promoter element, EMSA analysis of the putative MZF-1 site was performed with YT and HEK293 nuclear extracts. The previously characterized MZF-1-binding site from the CD34 promoter was used as a positive control. 22 Figure 3a shows the sequence of the oligonucleotide probes containing the predicted MZF-1 site in the KIR2DL1 and KIR3DL1 genes aligned with the functional MZF-1 site found in the human CD34 gene, as well as the consensus domain 1 and domain 2 sequences determined by oligonucleotide selection experiments. 21 Both of the MZF-1-binding domains contain central tracts of four cytidine residues, therefore mutated oligos contained disruptions of both domain 1 and domain 2 C-tracts. The KIR3DL1 element possesses several nucleotide differences that weaken the consensus domain 1 binding region, whereas KIR2DL1 has substitutions in the domain 2 consensus. Figure 3b shows that a distinct complex is formed in the HEK293 cell line with the CD34 and KIR probes, and this complex is absent from the YT cell nuclear extract. This complex was not generated when the mutated oligonucleotide probes were used. The higher intensity of the complex generated by the KIR2DL1 binding site may be due to the contiguous arrangement of the domain 1 and 2 consensus sequences, whereas there is an additional nucleotide separating these sites in the CD34 sequence. The reduced intensity of the complex formed by the KIR3DL1 probe is likely due to the significant disruption of the domain 1 binding consensus. Competition of the CD34 MZF-1 probe with unlabeled KIR2DL1 oligonucleotide resulted in the complete loss of the complex, whereas KIR2DL1 oligonucleotide with a mutated MZF-1-binding sequence had no effect. In addition, wild-type, but not mutated, CD34 oligonucleotide inhibited KIR2DL1 and KIR3DL1 complex formation, demonstrating the ability of this region to bind to MZF-1. The lack of a detectable complex in YT cells is consistent with this binding site contributing to the observed promoter activity in HEK293 but not YT cells. The band detected with the KIR2DL1 probes in YT cells likely represents the slightly higher molecular weight band that is also present in HEK293 cells. However, this band is not affected by disruption of the MZF-1 consensus in the mutant oligonucleotides, and it is not competed by the wild-type MZF-1 probe, and thus represents a non-MZF-1binding protein. 
Enforced expression of MZF-1 decreases KIR expression in developing NK cells
The complete overlap of the 3 0 end of the distal antisense with the proximal antisense suggests that the distal transcript should also be capable of producing the 28-base piRNA, and mediate a similar KIR silencing activity. However, as distal antisense transcription is limited to very early progenitor cells, it might function to prevent premature opening of the KIR loci by distal forward transcript in stem cells. Previous studies have demonstrated that the KIR loci are heavily methylated at the NK progenitor stage, consistent with enforced silencing occurring in precursor populations. 23 As in vitro analysis of the distal antisense promoter indicated a possible role for the MZF-1 transcription factor in progenitor cell-specific expression, we reasoned that enforced expression of MZF-1 would maintain distal antisense promoter activity in committed NK precursors and keep the KIR loci in their silent state. To address this hypothesis, we transduced primary CD34 þ hematopoietic progenitor cells with a retroviral vector expressing MZF-1 and differentiated these cells into mature CD56 þ NK cells in vitro.
The expression of KIR on the surface of mature NK cells was analyzed by FACS after 21 days in culture. Overexpression of MZF-1 resulted in a 75% reduction in KIR expression compared with eGFP control cells or GFP-negative cells present in the culture system (Figure 4a ). This effect was consistent and statistically significant in all donors tested (Figure 4c ). Total RNA was harvested from eGFP control or MZF-1-overexpressing cells and used for RT-PCR with primer sets that specifically amplify either MZF-1 mRNA or distal antisense transcripts. As expected, MZF-1 mRNA levels were increased in cultures transduced with the MZF-1-expressing virus (Figure 4b ). Distal antisense was detectable in MZF-1-containing cultures but absent from control populations, as previously observed (Figure 4d ). The silencing effect of enforced MZF-1 expression is likely due to the continued presence of distal antisense transcripts in developing NK cells leading to the production of the 28-base piRNA and KIR gene silencing, as previously shown for the proximal antisense transcript. 18 
DISCUSSION
Global transcriptome analysis has revealed that the majority (75%) of the human genome is transcribed into RNA, of which only B1% codes for protein. 24 There is an abundance of lncRNA, and it has been shown to function in many aspects of gene regulation such as genomic imprinting, gene silencing and gene activation. 25 The novel KIR antisense transcript identified in this study belongs to the gene body-associated class of lncRNA. A recent study of lncRNA expressed by human embryonic stem cells (hESCs) revealed that the majority of lncRNA (89%) are associated with the promoters, enhancers and bodies of protein-coding genes. 26 Furthermore, 5% of the lncRNAs were antisense transcripts originating within protein-coding genes like the KIR distal transcript identified in this study. The expression of the KIR distal antisense lncRNA by hESC and other cell types with stem cell properties, but not mature differentiated cell types, suggests a role in the initial silencing of KIR loci. In support of this hypothesis, differentiation of hESC into CD34-expressing cells resulted in a loss of distal antisense transcription. It is of interest to note that the MZF-1 transcription factor-binding site implicated in the function of the KIR distal antisense promoter is also present in the CD34 promoter. This suggests that additional factors contribute to the preferential expression of distal antisense in stem cells. MZF-1 is a bifunctional transcriptional regulator capable of activating transcription in cells of hematopoietic origins, while repressing transcription in other cell types. 20 The distal antisense transcript contains the 28-base element previously shown to mediate silencing initiated by the proximal antisense, predicting a similar silencing activity for the distal transcript. Enforced expression of MZF-1 during in vitro NK cell differentiation resulted in detectable levels of distal antisense and reduced levels of KIR expression consistent with a gene-silencing activity of the distal transcript. Therefore, the distal antisense may be generated in progenitor cells to ensure that the locus is silenced, ensuring that KIR are not expressed in other cell lineages during development, whereas the proximal antisense controls the probabilistic expression of KIR in mature NK. The presumed transient role of the KIR lncRNA in hESC may not be a general phenomenon of gene body-associated antisense lncRNAs, as differentiation of hESC into endoderm did not result in a decrease in the number of gene body-associated antisense lncRNAs. 26 The KIR gene family may represent a special case where it is important that the KIR genes are completely silenced in NK progenitors so that they do not have a negative impact on the process of NK cell differentiation. It is also of interest to note that the distinct 2DL1  CCCAGCACCCCAGG-GTCCCTTCTTCCTAGTTTA  2DL1m  A  TT  -A  3DL1  CCGAGCATCCGAGG-GTCCCCTCTTCCTAGTGTA  CD34  GCCTTCTCCCCAGTTATCCCCTCTCCAGCCCTGG  CD34m AA AA Consen ------TCCCCACT-TCCCCCTCNCCCG------ unspliced antisense transcript derived from a promoter in intron 1 of the KIR3DP1 pseudogene that was detected in Daudi and Jurkat cells ( In summary, we have shown that KIR antisense lncRNAs derived from a promoter in intron 2 are only expressed at the earliest stages of cell differentiation, and represent a distinct class of lncRNA capable of silencing genes in stem cells.
MATERIALS AND METHODS
Cell lines
H9 hESCs were obtained from WiCell (Madison, WI, USA). Ntera2 cells were kindly provided by Dr Peter Andrews (University of Sheffield, UK). HEK293T, Hela and Ntera2 cells were cultured in Dulbecco's modified Eagle medium containing 10% fetal bovine serum, 100 U ml À 1 penicillin, 100 U ml À 1 streptomycin (P/S), sodium pyruvate and L-glutamine. MCF7 cells were cultured in Dulbecco's modified Eagle medium as above with the addition of 0.01 mg ml À 1 human recombinant insulin. YT, Daudi, Jurkat, PC3 and U937 cells were cultured in RPMI 1640 media containing 10% fetal bovine serum, P/S and L-glutamine.
NK cell and CD34 þ HPC isolation
The use of all human tissue was approved by the Committee on the Use of Human Subjects in Research at the University of Minnesota, and informed consent was secured in accordance with the Declaration of Helsinki. Umbilical cord blood was obtained from full-term consenting mothers at Memorial Blood Bank (Minneapolis, MN, USA), Placental Blood Program of the New York Blood Center (New York, NY, USA), Saint Louis Cord Blood Bank (St Louis, MO, USA) or local obstetric units. Total mononuclear cells were separated from the peripheral blood of healthy donors by Histopaque (Sigma-Aldrich, St Louis, MO, USA) gradient centrifugation. CD56 þ NK cells were column-isolated by negative selection using magnetic beads (Miltenyi Biotech, Auburn, CA, USA). CD34 þ HPCs were isolated from umbilical cord blood donors by Histopaque gradient centrifugation followed by a double-column positive selection using anti-CD34 microbeads (Miltenyi). 
